Vaxcyte, Inc. SEC filings PCVX
Vaxcyte, Inc. has 767 filings in SEC EDGAR's recent list, going back to Jul 24, 2015. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 4, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2026 | Nov 4, 2026 |
| 8-K |
Current report
Material agreement, New debt, Other events
|
Oct 9, 2026 | Oct 6, 2026 |
| 424B5 | Prospectus supplement | Oct 8, 2026 | — |
| 424B5 | Prospectus supplement | Oct 8, 2026 | — |
| FWP | Free writing prospectus | Oct 7, 2026 | — |
| 305B2 | Filing | Oct 6, 2026 | — |
| 424B5 | Prospectus supplement | Oct 6, 2026 | — |
| 424B5 | Prospectus supplement | Oct 6, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 5, 2026 | Oct 5, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 3, 2026 | Aug 31, 2026 |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2026 | Aug 5, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 15, 2026 | Jul 13, 2026 |
| 8-K |
Current report
Officer or director change
|
Jun 23, 2026 | Jun 17, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 16, 2026 | Jun 15, 2026 |
| 10-Q | Quarterly report | May 6, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 6, 2026 | May 6, 2026 |
| ARS | Annual report to shareholders | Apr 23, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 23, 2026 | — |
| DEF 14A | Proxy statement | Apr 23, 2026 | Jun 15, 2026 |
| 8-K |
Current report
Other events
|
Feb 24, 2026 | Feb 24, 2026 |
| 424B5 | Prospectus supplement | Feb 24, 2026 | — |
| S-8 | Employee stock plan registration | Feb 24, 2026 | — |
| 10-K | Annual report | Feb 24, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 24, 2026 | Feb 24, 2026 |
| 8-K |
Current report
Other events
|
Feb 2, 2026 | Jan 29, 2026 |
| 424B5 | Prospectus supplement | Jan 30, 2026 | — |
| 424B5 | Prospectus supplement | Jan 29, 2026 | — |
| 8-K |
Current report
Officer or director change
|
Dec 19, 2025 | Dec 18, 2025 |
| 10-Q | Quarterly report | Nov 4, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2025 | Nov 4, 2025 |
| 8-K |
Current report
Material agreement
|
Sep 30, 2025 | Sep 24, 2025 |
| 10-Q | Quarterly report | Aug 6, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2025 | Aug 6, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 17, 2025 | Jun 12, 2025 |
| UPLOAD | Letter from the SEC | May 14, 2025 | — |
| CORRESP | Letter to the SEC | May 7, 2025 | — |
| 10-Q | Quarterly report | May 7, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 7, 2025 | May 7, 2025 |
| 8-K |
Current report
Officer or director change
|
May 1, 2025 | May 1, 2025 |
| ARS | Annual report to shareholders | Apr 28, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 28, 2025 | — |
| DEF 14A | Proxy statement | Apr 28, 2025 | Jun 12, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 18, 2025 | Jun 12, 2025 |
| UPLOAD | Letter from the SEC | Apr 10, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 31, 2025 | Mar 31, 2025 |
| S-8 | Employee stock plan registration | Feb 25, 2025 | — |
| 10-K | Annual report | Feb 25, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 25, 2025 | Feb 25, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Nov 21, 2024 | Nov 15, 2024 |
| 10-Q | Quarterly report | Nov 5, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2024 | Nov 5, 2024 |
| 8-K |
Current report
Other events
|
Sep 6, 2024 | Sep 4, 2024 |
| 424B5 | Prospectus supplement | Sep 5, 2024 | — |
| 424B5 | Prospectus supplement | Sep 3, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 3, 2024 | Sep 3, 2024 |
| 10-Q | Quarterly report | Aug 6, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2024 | Aug 6, 2024 |
| 8-K |
Current report
Officer or director change
|
Jul 2, 2024 | Jun 27, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 10, 2024 | Jun 6, 2024 |
| S-3ASR | Automatic shelf registration | May 24, 2024 | — |
| 10-Q | Quarterly report | May 8, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 8, 2024 | May 8, 2024 |
| ARS | Annual report to shareholders | Apr 15, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 15, 2024 | — |
| DEF 14A | Proxy statement | Apr 15, 2024 | Jun 6, 2024 |
| S-8 | Employee stock plan registration | Feb 27, 2024 | — |
| 10-K | Annual report | Feb 27, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 27, 2024 | Feb 27, 2024 |
| 424B5 | Prospectus supplement | Jan 31, 2024 | — |
| 8-K |
Current report
Other events
|
Jan 31, 2024 | Jan 30, 2024 |
| 424B5 | Prospectus supplement | Jan 30, 2024 | — |
| 8-K |
Current report
Officer or director change
|
Nov 28, 2023 | Nov 27, 2023 |
| 8-K |
Current report
Material agreement
|
Nov 27, 2023 | Nov 21, 2023 |
| 10-Q | Quarterly report | Nov 6, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2023 | Nov 6, 2023 |
| 8-K |
Current report
Material agreement
|
Oct 16, 2023 | Oct 13, 2023 |
| 8-K |
Current report
Material agreement
|
Oct 4, 2023 | Sep 28, 2023 |
| 8-K |
Current report
Material agreement
|
Sep 7, 2023 | Sep 1, 2023 |
| 10-Q | Quarterly report | Aug 8, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2023 | Aug 8, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 15, 2023 | Jun 13, 2023 |
| 10-Q | Quarterly report | May 8, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 8, 2023 | May 8, 2023 |
| ARS | Annual report to shareholders | Apr 28, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Apr 28, 2023 | — |
| DEF 14A | Proxy statement | Apr 28, 2023 | — |
| 424B5 | Prospectus supplement | Apr 20, 2023 | — |
| 8-K |
Current report
Other events
|
Apr 20, 2023 | Apr 18, 2023 |
| 424B5 | Prospectus supplement | Apr 17, 2023 | — |
| 8-K |
Current report
Other events
|
Apr 17, 2023 | Apr 17, 2023 |
| 8-K |
Current report
Material agreement
|
Mar 6, 2023 | Feb 28, 2023 |
| 424B5 | Prospectus supplement | Feb 27, 2023 | — |
| 8-K |
Current report
Other events
|
Feb 27, 2023 | Feb 27, 2023 |
| S-8 | Employee stock plan registration | Feb 27, 2023 | — |
| 10-K | Annual report | Feb 27, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Feb 27, 2023 | Feb 27, 2023 |
| S-3ASR | Automatic shelf registration | Dec 22, 2022 | — |
| 8-K |
Current report
Material agreement
|
Dec 20, 2022 | Dec 19, 2022 |
| 8-K |
Current report
Officer or director change
|
Dec 12, 2022 | Dec 6, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2022 | Nov 7, 2022 |
| 10-Q | Quarterly report | Nov 7, 2022 | Sep 30, 2022 |
| 424B5 | Prospectus supplement | Oct 27, 2022 | — |
| 8-K |
Current report
Other events
|
Oct 27, 2022 | Oct 25, 2022 |
| 424B5 | Prospectus supplement | Oct 24, 2022 | — |
| 8-K |
Current report
Other events
|
Oct 24, 2022 | Oct 24, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2022 | Aug 8, 2022 |
| 10-Q | Quarterly report | Aug 8, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 7, 2022 | Jun 1, 2022 |
| 8-K |
Current report
Results of operations
|
May 9, 2022 | May 9, 2022 |
| 10-Q | Quarterly report | May 9, 2022 | Mar 31, 2022 |
| DEFA14A | Additional proxy material | Apr 20, 2022 | — |
| DEF 14A | Proxy statement | Apr 20, 2022 | Jun 1, 2022 |
| 8-K |
Current report
Material agreement
|
Apr 18, 2022 | Apr 12, 2022 |
| S-8 | Employee stock plan registration | Feb 28, 2022 | — |
| 8-K |
Current report
Results of operations
|
Feb 28, 2022 | Feb 28, 2022 |
| 10-K | Annual report | Feb 28, 2022 | Dec 31, 2021 |
| 424B5 | Prospectus supplement | Jan 14, 2022 | — |
| 8-K |
Current report
Other events
|
Jan 13, 2022 | Jan 12, 2022 |
| 424B5 | Prospectus supplement | Jan 12, 2022 | — |
| 8-K |
Current report
Results of operations
|
Nov 10, 2021 | Nov 10, 2021 |
| 10-Q | Quarterly report | Nov 10, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Officer or director change
|
Oct 28, 2021 | Oct 26, 2021 |
| 8-K |
Current report
Officer or director change
|
Sep 20, 2021 | Sep 16, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2021 | Aug 11, 2021 |
| 10-Q | Quarterly report | Aug 11, 2021 | Jun 30, 2021 |
| S-3ASR | Automatic shelf registration | Jul 2, 2021 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 3, 2021 | Jun 2, 2021 |
| 8-K |
Current report
Results of operations
|
May 11, 2021 | May 11, 2021 |
| 10-Q | Quarterly report | May 11, 2021 | Mar 31, 2021 |
| DEFA14A | Additional proxy material | Apr 14, 2021 | — |
| DEF 14A | Proxy statement | Apr 14, 2021 | Jun 2, 2021 |
| S-8 | Employee stock plan registration | Mar 29, 2021 | — |
| 8-K |
Current report
Results of operations
|
Mar 29, 2021 | Mar 29, 2021 |
| 10-K | Annual report | Mar 29, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Officer or director change
|
Mar 25, 2021 | Mar 24, 2021 |
| 8-K |
Current report
Material agreement, New debt
|
Jan 25, 2021 | Jan 21, 2021 |
| 8-K |
Current report
Officer or director change
|
Dec 22, 2020 | Dec 16, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2020 | Nov 12, 2020 |
| 10-Q | Quarterly report | Nov 12, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2020 | Aug 12, 2020 |
| 10-Q | Quarterly report | Aug 12, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Jun 16, 2020 | Jun 16, 2020 |
| 424B4 | Prospectus | Jun 15, 2020 | — |
| S-8 | Employee stock plan registration | Jun 12, 2020 | — |
| EFFECT | Filing | Jun 11, 2020 | — |
| S-1MEF | Filing | Jun 11, 2020 | — |
| CERT | 8a cert | Jun 10, 2020 | — |
| 8-A12B | Filing | Jun 9, 2020 | — |
| CORRESP | Letter to the SEC | Jun 9, 2020 | — |
| CORRESP | Letter to the SEC | Jun 9, 2020 | — |
| S-1/A | Amended registration statement | Jun 8, 2020 | — |
| CORRESP | Letter to the SEC | May 22, 2020 | — |
| S-1 | Registration statement | May 22, 2020 | — |
| D | Filing | Apr 3, 2020 | — |
| UPLOAD | Letter from the SEC | Mar 27, 2020 | — |
| DRSLTR | Filing | Mar 13, 2020 | — |
| DRS/A | Filing | Mar 13, 2020 | — |
| UPLOAD | Letter from the SEC | Jan 21, 2020 | — |
| DRSLTR | Filing | Dec 31, 2019 | — |
| DRS/A | Filing | Dec 31, 2019 | — |
| UPLOAD | Letter from the SEC | Nov 8, 2019 | — |
| DRS | Filing | Oct 11, 2019 | — |
| D | Filing | Jun 12, 2018 | — |
| D | Filing | Mar 21, 2017 | — |
| D | Filing | Jul 24, 2015 | — |
Showing 167 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- PCVX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Carlos, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1649094
- Former names
- SutroVax, Inc. (until Apr 3, 2020)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.